These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2066856)

  • 1. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN; Francis DE; Halliday D
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein and leucine metabolism in maple syrup urine disease.
    Thompson GN; Bresson JL; Pacy PJ; Bonnefont JP; Walter JH; Leonard JV; Saudubray JM; Halliday D
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E654-60. PubMed ID: 2185648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose and alanine metabolism in children with maple syrup urine disease.
    Haymond MW; Ben-Galim E; Strobel KE
    J Clin Invest; 1978 Aug; 62(2):398-405. PubMed ID: 670400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
    Skvorak K; Liu J; Kruse N; Mehmood R; Das S; Jenne S; Chng C; Lao UL; Duan D; Asfaha J; Du F; Teadt L; Sero A; Ching C; Riggins J; Pope L; Yan P; Mashiana H; Ismaili MHA; McCluskie K; Huisman G; Silverman AP
    J Inherit Metab Dis; 2023 Nov; 46(6):1089-1103. PubMed ID: 37494004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
    Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of branched-chain amino acids in maple syrup urine disease.
    Schadewaldt P; Wendel U
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
    Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of hyperleucinemia in MSUD patients on leucine-free dietary therapy.
    Scott AI; Cusmano-Ozog K; Enns GM; Cowan TM
    Mol Genet Metab; 2017 Dec; 122(4):156-159. PubMed ID: 29032949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.
    Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P
    Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the acute crisis in maple syrup urine disease.
    Nyhan WL; Rice-Kelts M; Klein J; Barshop BA
    Arch Pediatr Adolesc Med; 1998 Jun; 152(6):593-8. PubMed ID: 9641714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of acute decompensation of neonatal maple syrup urine disease with continuous arteriovenous haemofiltration: report of one case.
    Lin MC; Chen CH; Fu LS; Jan SL; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2002; 43(5):281-4. PubMed ID: 12607485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
    Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
    Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
    Yıldız Y; Akcan Yıldız L; Dursun A; Tokatlı A; Coşkun T; Tekşam Ö; Sivri HS
    Eur J Pediatr; 2020 Jul; 179(7):1107-1114. PubMed ID: 32048023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts.
    Schadewaldt P; Wendel U
    Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.